ORIGINAL RESEARCH
Published on 01 Jul 2022
Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study
doi 10.3389/fonc.2022.811800
- 1,638 views
- 1 citation
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Molecular Targets for Treating Cancers in the Peritoneal Environment
Molecular Targets for Treating Cancers in the Peritoneal Environment
6,459
Total downloads
17k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 17 Mar 2022
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
doi 10.3389/fonc.2022.762820
- 2,336 views
- 13 citations
ORIGINAL RESEARCH
Published on 18 Nov 2021
Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
doi 10.3389/fonc.2021.739139
- 2,132 views
- 6 citations
ORIGINAL RESEARCH
Published on 07 Dec 2020
Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
doi 10.3389/fonc.2020.585079
- 1,828 views
- 7 citations
REVIEW
Published on 26 Nov 2020
A Ticket to Ride: The Implications of Direct Intercellular Communication via Tunneling Nanotubes in Peritoneal and Other Invasive Malignancies
doi 10.3389/fonc.2020.559548
- 5,049 views
- 24 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 17kTopic views
- 10kArticle views
- 6,459Article downloads